TrialThe journal of nutrition, health & aging2009

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study.

D Saumier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.